semaglutide baylor scott and white Beyond weight loss: Could GLP-1 agonists improve your heart health? Collaboration

This creates a buildup of glucose in the bloodstream, which can lead to high levels of both blood glucose and insulin in your bloodstream

Doses ranging from 0.25 mg to 1.0 mg daily have been investigated

This new class of medication proved to be so effective, it was fast-tracked for FDA-approval as a weight loss medication

This approach not only aids weight loss but can also improve overall health

Ones dosage of these prescription drugs is decided by their healthcare provider and depends on their condition, associated symptoms, and whether they have other chronic illnesses

The advent of novel pharmacologic weight loss approaches is changing the landscape for comorbidities such as diabetes, cardiovascular, and renal dysfunction in patients with obesity